Gregory Borchardt
Co-Founder and Managing Partner @ Caerus Ventures
Rockledge, United States
Gregory Borchardt is a Series A investor at Caerus Ventures in Rockledge focused on Fitness and Health Care. Gregory Borchardt is the Co-Founder and Managing Partner of Caerus Ventures. He attended the University of Pennsylvania.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Gregory Borchardt invests in
Stages Gregory Borchardt invests in
Countries Gregory Borchardt invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Fitness 1 (25%)
- Health Care 1 (25%)
Stage
- Series A 2 (50%)
- Seed 1 (25%)
- Funding Round 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Skulpt was founded in 2009 by Dr. Seward Rutkove, Neurology Professor of Harvard Medical School, and Dr. Jose Bohorquez, Electrical Engineering PhD from MIT. The company develops hardware and software to help athletes and fitness enthusiasts understand their body composition and give them the intelligence to help optimize their training and reachtheir peak performance. The patented technology, Composition Myography (CM), measures muscle quality and fat content of each major muscle group, giving an unprecedented level of insight into an athlete's body. The Skulpt Muscle Scanner is the world's first and only handheld consumer device that measures individual muscle quality (MQ) and total body fat percentage. The Skulpt app delivers training programs tailored to the unique physique of each user, providing targeted training for optimal results.Initially a medical company, Skulpt has been awarded numerous grants from the National Science Foundation and National Institute of Health to develop CM and validate it through various clinical research trials.Composition Myography has been adopted by dozens of US hospitals and pharmaceutical companies to track the progression of patients with neuromuscular disorders. In 2013, Skulpt began to develop consumer products based on CM technology. Skulpt’s first consumer product, the Aim, was the first-ever electronic to measure muscle quality and the fat content of individual body areas. In March 2016, the company launched the next generation of the Aim, the Chisel Muscle Scanner and an accompanying iOS and Android app. | $6.2M / Series A / Nov 17, 2015 | ||
| PBC Tech has designed a game-changing ultrathin supercapacitor with industry-team01 leading performance. Supercapacitors enable companies to use smaller batteries without compromising energy or peak performance and the company’s patented form factor solution allows for revolutionary size changes in wearables, accessories, and mobile electronics.The company’s products provide scalable voltage, energy, and power in a single, ultrathin package. The long-life, environmentally-friendly device works with existing lithium batteries, reducing waste, and fits in or around existing components. The company’s innovative business model and technology garnered recognition as a TIE50 2013 awardee and multiple competitive awards from NY State Energy and Research Development Authority. | $3M / Series A / Jun 05, 2014 | ||
| Skulpt was founded in 2009 by Dr. Seward Rutkove, Neurology Professor of Harvard Medical School, and Dr. Jose Bohorquez, Electrical Engineering PhD from MIT. The company develops hardware and software to help athletes and fitness enthusiasts understand their body composition and give them the intelligence to help optimize their training and reachtheir peak performance. The patented technology, Composition Myography (CM), measures muscle quality and fat content of each major muscle group, giving an unprecedented level of insight into an athlete's body. The Skulpt Muscle Scanner is the world's first and only handheld consumer device that measures individual muscle quality (MQ) and total body fat percentage. The Skulpt app delivers training programs tailored to the unique physique of each user, providing targeted training for optimal results.Initially a medical company, Skulpt has been awarded numerous grants from the National Science Foundation and National Institute of Health to develop CM and validate it through various clinical research trials.Composition Myography has been adopted by dozens of US hospitals and pharmaceutical companies to track the progression of patients with neuromuscular disorders. In 2013, Skulpt began to develop consumer products based on CM technology. Skulpt’s first consumer product, the Aim, was the first-ever electronic to measure muscle quality and the fat content of individual body areas. In March 2016, the company launched the next generation of the Aim, the Chisel Muscle Scanner and an accompanying iOS and Android app. | $1.7M / Seed / Apr 29, 2014 | ||
| Grain & Barrel Spirits is an innovation-driven alcohol beverage company adept at identifying emerging trends and monetizing them with nimble new product development. Leveraging one of the most successful independent brand launches of the past year in Chicken Cock Whiskey ($1.6 million + in sales), Grain & Barrel Spirits has created anincubator platform designed to develop, test and scale brands. Operating within a highly acquisitive industry where large suppliers lack internal innovation and therefore must acquire it, Grain & Barrel Spirits's goal is to monetize brand successes on a recurring basis, while having a consistent pipeline of new product development targeting niche, but highly scalable, on-trend opportunities.Grain & Barrel Spirits is raising up to $2 million in growth capital to fund expansion of its current portfolio of successful alcohol beverage brands and further build out a robust brand development and sales platform. In order to keep up with the demands of rapid expansion and production, Grain & Barrel Spirits will also be using this raise to build a significant working capital reserve. | Mar 02, 2013 |
Co-Investors
About Caerus Ventures
Caerus Ventures invests in early stage technology companies at the convergence of hardware and software.
Caerus Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Gregory Borchardt
Co-Founder and Managing Partner
|
|||
Brodi Jackson
Managing Partner
|
|||
Sarah Hassan
Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Gregory Borchardt invest in?
Gregory Borchardt invests primarily in Fitness and Health Care startups, most often at Series A and Seed stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Gregory Borchardt?
Public channels for Gregory Borchardt include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Gregory Borchardt last invest?
The most recent investment recorded for Gregory Borchardt closed in Nov 2015. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
